SARS-CoV-2 caused a surge in antibiotic consumption causing a silent pandemic inside the pandemic. A retrospective analysis of Italian data in the first half of 2022

Munkholm, 2020, The global governance of antimicrobial resistance: a cross-country study of alignment between the global action plan and national action plans, Global Health, 16, 109, 10.1186/s12992-020-00639-3 O’Neill J [Internet]. Tackling drug-resistant infections globally: final report and recommendations. https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf.[updated 2016, May]. Naylor, 2018, Estimating the burden of antimicrobial resistance: a systematic literature review, Antimicrob Resist Infect Control, 7, 58, 10.1186/s13756-018-0336-y Report to the Secretary-General of the United Nations [Internet]. UN Interagency Coordination Group on Antimicrobial Resistance: No Time to Wait: Securing the future from drug-resistant infections. https://www.who.int/publications/i/item/no-time-to-wait-securing-the-future-from-drug-resistant-infections.[updated 2019, April, 29]. World, 2017 Patel, 2022, The pandemic legacy of antimicrobial resistance in the USA, Lancet, 3, e726 Vitiello, 2022, A short focus, azithromycin in the treatment of respiratory viral infection COVID-19: efficacy or inefficacy?, Immunol Res, 70, 129, 10.1007/s12026-021-09244-x Ferrara, 2022, COVID-19 mRNA Vaccines: A Retrospective Observational Pharmacovigilance Study, Clin Drug Investig, 42, 1065, 10.1007/s40261-022-01216-9 Vitiello, 2022, COVID-19 pandemic: vaccine and new monoclonal antibodies, point of view, Ir J Med Sci, 191, 487, 10.1007/s11845-021-02584-5 Ferrara, 2022, Nirmatrelvir–remdesivir association for non-hospitalized adults with COVID-19, point of view, Inflammopharmacology, 30, 1927, 10.1007/s10787-022-01055-2 World Health Organization (WHO). https://www.who.int/publications/m/item/tripartite-amr-country-self-assessment-survey-(tracss)-2020-2021. [Accessed November 2022]. Ghosh, 2021, Antimicrobial Resistance Threats in the emerging COVID-19 pandemic: where do we stand?, J Infect Public Health, 14, 555, 10.1016/j.jiph.2021.02.011 Ohmagari, 2019, National Action Plan on Antimicrobial Resistance (AMR) 2016–2020 and relevant activities in Japan, Glob Health Med, 1, 71, 10.35772/ghm.2019.01017 Hoffman, 2015, What Will It Take to Address the Global Threat of Antibiotic Resistance?, J Law Med Ethics, 43, 363, 10.1111/jlme.12253 Padiyara, 2018, Global Governance Mechanisms to Address Antimicrobial Resistance, Infect Dis (Auckl), 11, 10.1177/1178633718767887 Rochford, 2018, Global governance of antimicrobial resistance, Lancet, 391, 1976, 10.1016/S0140-6736(18)31117-6 Rubin, 2019, The glocalization of antimicrobial stewardship, Global Health, 15, 54, 10.1186/s12992-019-0498-2 Rogers Van Katwyk, 2020, Exploring Models for an International Legal Agreement on the Global Antimicrobial Commons: Lessons from Climate Agreements, Health Care Anal Lomazzi, 2019, Antimicrobial resistance - moving forward?, BMC Public Health, 19, 858, 10.1186/s12889-019-7173-7 World Health Organization (WHO), 2019 Ruckert, 2020, Governing antimicrobial resistance: a narrative review of global governance mechanisms, J Public Health Policy, 41, 515, 10.1057/s41271-020-00248-9 World Health Organization (WHO), 2015 WHO, FAO, OIE, 2020 Tsai, 2020, Are countries’ self-reported assessments of their capacity for infectious disease control reliable? Associations among countries’ self-reported international health regulation 2005 capacity assessments and infectious disease control outcomes, BMC Public Health, 20, 282, 10.1186/s12889-020-8359-8 Italian Medicines Agency–AIFA. https://www.aifa.gov.it/web/guest/uso-dei-farmaci-in-italia. [Accessed Dicember 2022]. Zovi, 2021, Medicines shortages and the perception of healthcare professionals working in hospitals: an Italian case study, J Interprofessional Educ Pract, 10.1016/j.xjep.2021.100472 Crofts, 2017, Next-generation approaches to understand and combat the antibiotic resistome, Nat Rev Microbiol, 15, 422, 10.1038/nrmicro.2017.28 Wan, 2021, Novel strategy to combat antibiotic resistance: a sight into the combination of CRISPR/Cas9 and nanoparticles, Pharmaceutics, 13, 352, 10.3390/pharmaceutics13030352 Garvey, 2020, Bacteriophages and the one health approach to combat multidrug resistance: is this the way?, Antibiotics (Basel), 9, 414, 10.3390/antibiotics9070414 Campania Region. Antibiotic Resistance and Care-Related Infections - Antibiotic Resistance and Care-Related Infections. https://regione.campania.it. [Accessed December 2022]. Vitiello, 2022, Pandemic COVID-19, an update of current status and new therapeutic strategies, Naunyn Schmiedebergs Arch Pharmacol, 395, 1159, 10.1007/s00210-022-02265-9